CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock

Condition:   Shock, Cardiogenic Interventions:   Drug: Dobutamine;   Drug: Milrinone;   Drug: Normal Saline Sponsor:   Ottawa Heart Institute Research Corporation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials